LDXHealth CareCompany Update15 Sept 202615 September 2026· 2 min read
Lumos Diagnostics (ASX: LDX) Expands FebriDx US Footprint to 215 Sites
Lumos Diagnostics has increased FebriDx’s US footprint to 215 live sites and 405 sites under evaluation. Two top-100 urgent care groups will roll out the test across more than 40 combined locations.